Market revenue in 2024 | USD 64.0 million |
Market revenue in 2030 | USD 80.1 million |
Growth rate | 3.6% (CAGR from 2025 to 2030) |
Largest segment | Atopic dermatitis |
Fastest growing segment | Allergic contact dermatitis |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Atopic dermatitis, Allergic contact dermatitis, Urticaria, Other Diseases |
Key market players worldwide | AbbVie Inc, Teva Pharmaceutical Industries Ltd, Amgen Inc, Astellas Pharma Inc, Bristol-Myers Squibb Co, Cara Therapeutics Inc, GlaxoSmithKline, Viatris Inc, Novartis AG ADR, Pfizer Inc, Sanofi SA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pruritus therapeutics market will help companies and investors design strategic landscapes.
Atopic dermatitis was the largest segment with a revenue share of 41.72% in 2024. Horizon Databook has segmented the South Africa pruritus therapeutics market based on atopic dermatitis, allergic contact dermatitis, urticaria, other diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa pruritus therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa pruritus therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related statistics found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account